Drugs / Dihydrexidine
Dihydrexidine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00000348 | — | cocaine dependence | National Institute on Drug Abuse (NIDA) | Unknown | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02507206 | Apr 2013 → Jan 2018 | schizotypal personality disorder | Antonia New | Completed | No outcome recorded |
| Phase 2 | NCT01466205 | Jan 2011 → Jan 2013 | cognitive disorder, schizotypal personality disorder | Larry J. Siever | Unknown | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dihydrexidine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000348 ↗ |
| Known as | DAR 0-100A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02507206 ↗ |
| Known as | DAR-0100 | ChEMBL registry synonym — accepted as the source's own label CHEMBL25856 ↗ |
| Known as | DHX | “The purpose of this study is to evaluate safety issues pertaining to dihydrexidine (DHX), to cocaine, and to its interaction” NCT00000348 ↗ |
| Known as | DIHYDREXIDINE HYDROCHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL25856 ↗ |
| Known as | Rel-dihydrexidine | ChEMBL registry synonym — accepted as the source's own label CHEMBL25856 ↗ |
| Action | Activate | “is a full D1R agonist” NCT01466205 ↗ |
| Modality | Small molecule | — CHEMBL25856 ↗ |
| Route | Intravenous | “administered intravenously” NCT01466205 ↗ |